SA
Create Free Alerts
Prenetics Global LimitedPRENASDAQ
Loading
OverviewIntelligenceChartsNews

Latest News

BNP PARIBAS ACCELERATES ASSET MANAGEMENT GROWTH WITH PRE-TAX INCOME SET TO DOUBLE BY 2030
globenewswire.com

BNP PARIBAS ACCELERATES ASSET MANAGEMENT GROWTH WITH PRE-TAX INCOME SET TO DOUBLE BY 2030

BNP PARIBAS ACCELERATES ASSET MANAGEMENT GROWTH WITH PRE-TAX INCOME SET TO DOUBLE BY 2030 PRESS RELEASE Paris, 17 March 2026 BNP Paribas today unveiled its 2030 Strategic Plan for its scaled and integrated Asset Management platform, positioning it as a key contributor to the Group's trajectory toward a 13% Return on Tangible Equity by 2028. Building on the successful acquisition of AXA IM, BNP Paribas Asset Management now operates at scale across Europe, marking a transformational step in its growth.

Top Small-Cap Stocks Leading The Market Rotation
seekingalpha.com

Top Small-Cap Stocks Leading The Market Rotation

Small-cap stocks are crushing the market amid a major rotation away from mega tech as market breadth strengthens, boosted by declining interest rates, solid earnings, and a resilient economy. Every member of the Magnificent 7 has underperformed in 2026, with investors increasingly worried about AI capex spending and stretched valuations. Roughly 65% of Russell 2000 companies have topped Q4 earnings expectations, the best beat rate since 2021.

Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
globenewswire.com

Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity

Final Milestone in Strategic Transformation Positions Company to Accelerate IM8 Global Expansion with Zero Debt Q4 and Full-Year 2025 Financial Results to be Announced on February 18, 2026 NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced the completion of the sale of its 35% equity interest in Insighta to Tencent for total cash consideration of $70 million. The transaction provides a substantial and immediate increase in Prenetics' cash resources, further strengthening the Company's financial position as it sharpens its focus on the global expansion of IM8, its flagship consumer health brand.

Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors
globenewswire.com

Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors

Appointment Strengthens Board with Deep Clinical and Commercial Expertise in Healthspan Optimization, Aligning with IM8 Growth Strategy NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced the appointment of Dr. Darshan Shah as an independent director to its Board of Directors (the “Board”), effective February 16, 2026. Dr. Shah will also serve as a member of the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee.

Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
globenewswire.com

Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity

Final Milestone in Strategic Transformation Positions Company to Accelerate IM8 Global Expansion with Zero Debt Q4 and Full-Year 2025 Financial Results to be Announced Pre-Market on February 18, 2026 NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced the completion of the sale of its 35% equity interest in Insighta to Tencent for total cash consideration of $70 million. The transaction provides a substantial and immediate increase in Prenetics' cash resources, further strengthening the Company's financial position as it sharpens its focus on the global expansion of IM8, its flagship consumer health brand.

Formula 1 Phenom Ollie Bearman Joins Prenetics' IM8 Health as Global Ambassador and Shareholder
globenewswire.com

Formula 1 Phenom Ollie Bearman Joins Prenetics' IM8 Health as Global Ambassador and Shareholder

NEW YORK, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced Formula 1 phenom Ollie Bearman as its newest Global Ambassador and a shareholder. This partnership marks another milestone for IM8 as it continues to capture interest and align with world-class athletes who embody peak performance and a commitment to health excellence.

Contrasting Neuphoria Therapeutics (NASDAQ:NEUP) & Prenetics Global (NASDAQ:PRE)
defenseworld.net

Contrasting Neuphoria Therapeutics (NASDAQ:NEUP) & Prenetics Global (NASDAQ:PRE)

Prenetics Global (NASDAQ: PRE - Get Free Report) and Neuphoria Therapeutics (NASDAQ: NEUP - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends. Institutional and Insider Ownership 25.0% of Prenetics

Prenetics Global: Is Undervalued, Supported By Portfolio Optimization In 2026 (Buy)
seekingalpha.com

Prenetics Global: Is Undervalued, Supported By Portfolio Optimization In 2026 (Buy)

Prenetics Global Limited is rated a buy, with a projected 150% upside based on forward EV/S and robust revenue growth from IM8. PRE has been working to reduce its direct costs, with a sequential improvement of 9% (QoQ) while increasing IM8's gross margin by 8 percentage points on a sequential basis. My calculation shows that Prenetics Global has a cash runway of about 18 months with a net burn rate of about $25 million in nine months.

Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure
globenewswire.com

Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure

CHARLOTTE, N.C., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced that it has entered into warrant exchange agreements, subject to customary closing conditions, with holders representing approximately 83.4% of its outstanding Class A and Class B warrants, pursuant to a voluntary warrant exchange program designed to simplify the Company's capital structure and materially reduce potential future dilution.

Prenetics Global (NASDAQ:PRE) Shares Up 3.2% – Here’s What Happened
defenseworld.net

Prenetics Global (NASDAQ:PRE) Shares Up 3.2% – Here’s What Happened

Prenetics Global Limited (NASDAQ: PRE - Get Free Report) shares were up 3.2% during trading on Thursday. The stock traded as high as $16.97 and last traded at $16.49. Approximately 170,202 shares traded hands during trading, an increase of 25% from the average daily volume of 136,406 shares. The stock had previously closed at $15.98.

Prenetics Announces Upcoming Conference Participation
globenewswire.com

Prenetics Announces Upcoming Conference Participation

CHARLOTTE, N.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced its participation in the following upcoming investor conferences.

Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 Million
globenewswire.com

Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 Million

CHARLOTTE, N.C., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), the parent company of IM8 and a global health-tech and longevity company pioneering a dual-engine strategy across consumer wellness and Bitcoin, today announced that all key members of its executive leadership team have executed open market purchases of Prenetics' common stock during the Company's designated trading window.

H&M LAUNCHES NEW CONCEPT STORE IN BEVERLY HILLS, INTRODUCING H&M PRE-LOVED TO L.A.
prnewswire.com

H&M LAUNCHES NEW CONCEPT STORE IN BEVERLY HILLS, INTRODUCING H&M PRE-LOVED TO L.A.

H&M CELEBRATES OPENING WITH AMELIA GRAY, DELILAH BELLE, JULEZ SMITH, AND TINA KNOWLES LOS ANGELES , Nov. 20, 2025 /PRNewswire/ -- Today, H&M opened its first-ever location in Beverly Hills at 370 North Beverly Drive. This special destination store focuses on offering the most fashion-forward womenswear through a handpicked curation of H&M's most elevated designs, special collections, accessories, and H&M Pre-Loved.

Cantor Fitzgerald Reiterates Overweight Rating on Prenetics with Price Target of $31 Following Strong IM8 Growth
globenewswire.com

Cantor Fitzgerald Reiterates Overweight Rating on Prenetics with Price Target of $31 Following Strong IM8 Growth

IM8's Strong Unit Economics—60% Margins and 3.9-Month Payback—Central to Cantor's Bullish Outlook Cantor Notes PRE's ~$120M Liquidity and 387 BTC Treasury as Strengthening the Company's Financial Position Cantor Forecasts $217 Million in FY2026 Revenue as IM8 Expands Internationally and Sharpens Strategic Focus CHARLOTTE, N.C., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced that Cantor Fitzgerald has reiterated its Overweight rating on the Company in its latest equity research report dated November 11, 2025, while updating its 12-month price target to $31, compared to its prior target of $32.

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance